The global high content screening market is on the cusp of remarkable expansion, with the market value surpassing USD 1.7 billion in 2023. Propelled by rising demand in pharmaceutical research and drug discovery, the HCS market is expected to grow at a compound annual growth rate (CAGR) of 5.8%, reaching an impressive USD 3 billion by 2033.
High content screening, also referred to as cellomics, plays a crucial role in identifying new drug candidates. This advanced technique integrates digital microscopy and flow cytometry, coupled with IT systems that store and analyze biological data. These systems are increasingly being utilized by the pharmaceutical industry for characterizing preclinical drugs, significantly enhancing drug development processes.
With its wide-ranging applications, including the use of chemical genetics to study biological systems, HCS technology is anticipated to grow exponentially in the near future.
Key Market Insights:
- The global market recorded a 5.1% CAGR over the previous period.
- India is projected to witness a robust CAGR of 6.6% in the coming years.
- Germany accounted for more than 7.3% of all demand in Europe in 2022, positioning itself as a key market player.
- China’s HCS market is expected to grow at an impressive 7.8% CAGR over the next decade.
- The pharmaceutical and healthcare industries are driving the highest demand for high content screenings.
“The increasing prevalence of various infectious diseases with complex symptoms is fueling the demand for innovative treatment solutions. As a result, biotechnology and pharmaceutical research and development efforts are intensifying, with imaging technologies becoming a critical component in drug discovery and analysis,” says an FMI analyst.
Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!
Competitive Landscape:
Key players in the high content screening market are expanding their presence through mergers, acquisitions, product launches, and strategic collaborations.
- Particle Works, a company at the forefront of particle engineering platforms, introduced the Automated Library Synthesis (ALiS) System in November 2022. This innovative platform automates early-stage drug creation and high-throughput evaluation of lipid nanoparticle (LNP) formulations and mRNA candidates.
- In April 2022, Twist Bioscience Corporation launched its Twist High Throughput Antibody Production platform, enabling customers to transform genetic sequences into purified antibodies for use in screening and therapeutic discovery.
The high content screening market is set to witness accelerated growth as industries continue to harness cutting-edge technology to drive advancements in drug discovery and development.
Key Companies Profiled:
- Thermo Fisher Scientific Inc.
- Becton Dickinson, and Company
- GE Healthcare
- Olympus Corporation
- PerkinElmer Inc.
- Sysmex Corporation
- Merck KGaA
- Danaher Corporation
- Yokogawa Electric Corporation
- BioTek Instruments Inc.
Key Segments Profiled in the High Content Screening Industry Survey:
Product Type:
- Cell Imaging & Analysis
- HCS Instruments
- High-End HCS
- Mid End HCS
- Low-End HCS
- Flow Cytometers
- HCS Instruments
- Consumables
- Microplates
- Reagents & Assay Kits
- Other Consumables
- Software
- Services
Industry:
- Pharmaceutical & Healthcare
- Biotechnology
- Educational Institutions
- Independent CRO
- Government Organizations
- Others
Application:
- Primary & Secondary Screening
- Target Identification & Validation
- Toxicity Studies
- Compound Profiling
- Others
Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
